“Researchers from the University of Louisville School of Dentistry, were recently awarded a $1.7 million grant from the National Institutes of Health to study whether an anti-HIV drug could also be used to control periodontal diseases. The study of the drug, AMD3100, led by Professor George Hajishengallis from the school’s Centre for Oral Systemic Disease, will investigate the interactions between receptors, white blood cells and P.gingivalis bacteria.”

Click here for entire article.